Bilaketaren emaitzak - David B. Weiner

Findu emaitzak
  1. 1
    DNA vaccines: developing new strategies to enhance immune responses

    DNA vaccines: developing new strategies to enhance immune responses nork Shaheed Abdulhaqq, David B. Weiner

    Argitaratua 2008
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    DNA vaccines: prime time is now

    DNA vaccines: prime time is now nork E. Gary, David B. Weiner

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Developing DNA vaccines that call to dendritic cells

    Developing DNA vaccines that call to dendritic cells nork Michele A. Kutzler, David B. Weiner

    Argitaratua 2004
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Enhancement of human immunodeficiency virus type 1‐DNA vaccine potency through incorporation of T‐helper 1 molecular adjuvants

    Enhancement of human immunodeficiency virus type 1‐DNA vaccine potency through incorporation of T‐helper 1 molecular adjuvants nork Sandra A. Calarota, David B. Weiner

    Argitaratua 2004
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Interleukin 33: a switch-hitting cytokine

    Interleukin 33: a switch-hitting cytokine nork Daniel O. Villarreal, David B. Weiner

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Electroporation delivery of DNA vaccines: prospects for success

    Electroporation delivery of DNA vaccines: prospects for success nork Niranjan Y. Sardesai, David B. Weiner

    Argitaratua 2011
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    DNA vaccines: ready for prime time?

    DNA vaccines: ready for prime time? nork Michele A. Kutzler, David B. Weiner

    Argitaratua 2008
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    DNA vaccination: antigen presentation and the induction of immunity

    DNA vaccination: antigen presentation and the induction of immunity nork Devon J. Shedlock, David B. Weiner

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency

    Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency nork David N. Levy, Yosef Refaeli, David B. Weiner

    Argitaratua 1995
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product.

    The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. nork Yosef Refaeli, David N. Levy, David B. Weiner

    Argitaratua 1995
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials

    Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials nork Devon J. Shedlock, Guido Silvestri, David B. Weiner

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade

    DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade nork Malavika S. Giri, Kenneth E. Ugen, David B. Weiner

    Argitaratua 2004
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies

    In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies nork Ami Patel, Mamadou A. Bah, David B. Weiner

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells

    Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells nork Michael A. Chattergoon, Tara M. Robinson, Jean Boyer, David B. Weiner

    Argitaratua 1998
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr

    Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr nork Sundarasamy Mahalingam, Velpandi Ayyavoo, Milloni Patel, Thomas Kieber‐Emmons, David B. Weiner

    Argitaratua 1997
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1.

    Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. nork David N. Levy, Yosef Refaeli, Rob Roy MacGregor, David B. Weiner

    Argitaratua 1994
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    DNA vaccines for targeting bacterial infections

    DNA vaccines for targeting bacterial infections nork Mariana Ingolotti, Omkar U. Kawalekar, Devon J. Shedlock, Kar Muthumani, David B. Weiner

    Argitaratua 2010
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Immunogenicity of novel consensus-based DNA vaccines against avian influenza

    Immunogenicity of novel consensus-based DNA vaccines against avian influenza nork Dominick J. Laddy, Jian Yan, Natasha Corbitt, Darwyn Kobasa, Gary Kobinger, David B. Weiner

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4<sup>+</sup>T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

    DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4<sup>+</sup>T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo nork Jeong‐Im Sin, Jong J. Kim, Catherine J. Pachuk, C Satishchandran, David B. Weiner

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab

    Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab nork Kar Muthumani, Seleeke Flingai, Megan C. Wise, Colleen Tingey, Kenneth E. Ugen, David B. Weiner

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: